Global Human Growth Hormone Drugs Market Growth 2025-2031
The global Human Growth Hormone Drugs market size is predicted to grow from US$ 267 million in 2025 to US$ 344 million in 2031; it is expected to grow at a CAGR of 4.3% from 2025 to 2031.
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LP Information, Inc. (LPI) ' newest research report, the ?Human Growth Hormone Drugs Industry Forecast? looks at past sales and reviews total world Human Growth Hormone Drugs sales in 2024, providing a comprehensive analysis by region and market sector of projected Human Growth Hormone Drugs sales for 2025 through 2031. With Human Growth Hormone Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Human Growth Hormone Drugs industry.
This Insight Report provides a comprehensive analysis of the global Human Growth Hormone Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Human Growth Hormone Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Human Growth Hormone Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Human Growth Hormone Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Human Growth Hormone Drugs.
This report presents a comprehensive overview, market shares, and growth opportunities of Human Growth Hormone Drugs market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Human Growth Hormone Drugs market?
What factors are driving Human Growth Hormone Drugs market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Human Growth Hormone Drugs market opportunities vary by end market size?
How does Human Growth Hormone Drugs break out by Type, by Application?
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LP Information, Inc. (LPI) ' newest research report, the ?Human Growth Hormone Drugs Industry Forecast? looks at past sales and reviews total world Human Growth Hormone Drugs sales in 2024, providing a comprehensive analysis by region and market sector of projected Human Growth Hormone Drugs sales for 2025 through 2031. With Human Growth Hormone Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Human Growth Hormone Drugs industry.
This Insight Report provides a comprehensive analysis of the global Human Growth Hormone Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Human Growth Hormone Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Human Growth Hormone Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Human Growth Hormone Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Human Growth Hormone Drugs.
This report presents a comprehensive overview, market shares, and growth opportunities of Human Growth Hormone Drugs market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Norditropin
- Genotropin
- Humatrope
- Saizen
- Omnitrope - the Somatropin Biosimilar
- Somatropin Biopartners
- Prader-Willi Syndrome
- Turner Syndrome
- Short Stature Homeobox Gene
- Small for Gestational Age
- Chronic Renal Insufficiency
- Short Bowel Syndrome
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Eli Lilly and Company (US)
- Ferring Holding SA (Switzerland)
- Genentech, Inc. (US)
- GeneScience Pharmaceuticals Co., Ltd. (China)
- Merck KgaA (Germany)
- Novo Nordisk A/S (Denmark)
- Pfizer, Inc. (US)
- Sandoz International GmbH (Germany)
What is the 10-year outlook for the global Human Growth Hormone Drugs market?
What factors are driving Human Growth Hormone Drugs market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Human Growth Hormone Drugs market opportunities vary by end market size?
How does Human Growth Hormone Drugs break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Human Growth Hormone Drugs Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Human Growth Hormone Drugs by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Human Growth Hormone Drugs by Country/Region, 2020, 2024 & 2031
2.2 Human Growth Hormone Drugs Segment by Type
2.2.1 Norditropin
2.2.2 Genotropin
2.2.3 Humatrope
2.2.4 Saizen
2.2.5 Omnitrope - the Somatropin Biosimilar
2.2.6 Somatropin Biopartners
2.3 Human Growth Hormone Drugs Sales by Type
2.3.1 Global Human Growth Hormone Drugs Sales Market Share by Type (2020-2025)
2.3.2 Global Human Growth Hormone Drugs Revenue and Market Share by Type (2020-2025)
2.3.3 Global Human Growth Hormone Drugs Sale Price by Type (2020-2025)
2.4 Human Growth Hormone Drugs Segment by Application
2.4.1 Prader-Willi Syndrome
2.4.2 Turner Syndrome
2.4.3 Short Stature Homeobox Gene
2.4.4 Small for Gestational Age
2.4.5 Chronic Renal Insufficiency
2.4.6 Short Bowel Syndrome
2.5 Human Growth Hormone Drugs Sales by Application
2.5.1 Global Human Growth Hormone Drugs Sale Market Share by Application (2020-2025)
2.5.2 Global Human Growth Hormone Drugs Revenue and Market Share by Application (2020-2025)
2.5.3 Global Human Growth Hormone Drugs Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Human Growth Hormone Drugs Breakdown Data by Company
3.1.1 Global Human Growth Hormone Drugs Annual Sales by Company (2020-2025)
3.1.2 Global Human Growth Hormone Drugs Sales Market Share by Company (2020-2025)
3.2 Global Human Growth Hormone Drugs Annual Revenue by Company (2020-2025)
3.2.1 Global Human Growth Hormone Drugs Revenue by Company (2020-2025)
3.2.2 Global Human Growth Hormone Drugs Revenue Market Share by Company (2020-2025)
3.3 Global Human Growth Hormone Drugs Sale Price by Company
3.4 Key Manufacturers Human Growth Hormone Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Human Growth Hormone Drugs Product Location Distribution
3.4.2 Players Human Growth Hormone Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR HUMAN GROWTH HORMONE DRUGS BY GEOGRAPHIC REGION
4.1 World Historic Human Growth Hormone Drugs Market Size by Geographic Region (2020-2025)
4.1.1 Global Human Growth Hormone Drugs Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Human Growth Hormone Drugs Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Human Growth Hormone Drugs Market Size by Country/Region (2020-2025)
4.2.1 Global Human Growth Hormone Drugs Annual Sales by Country/Region (2020-2025)
4.2.2 Global Human Growth Hormone Drugs Annual Revenue by Country/Region (2020-2025)
4.3 Americas Human Growth Hormone Drugs Sales Growth
4.4 APAC Human Growth Hormone Drugs Sales Growth
4.5 Europe Human Growth Hormone Drugs Sales Growth
4.6 Middle East & Africa Human Growth Hormone Drugs Sales Growth
5 AMERICAS
5.1 Americas Human Growth Hormone Drugs Sales by Country
5.1.1 Americas Human Growth Hormone Drugs Sales by Country (2020-2025)
5.1.2 Americas Human Growth Hormone Drugs Revenue by Country (2020-2025)
5.2 Americas Human Growth Hormone Drugs Sales by Type (2020-2025)
5.3 Americas Human Growth Hormone Drugs Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Human Growth Hormone Drugs Sales by Region
6.1.1 APAC Human Growth Hormone Drugs Sales by Region (2020-2025)
6.1.2 APAC Human Growth Hormone Drugs Revenue by Region (2020-2025)
6.2 APAC Human Growth Hormone Drugs Sales by Type (2020-2025)
6.3 APAC Human Growth Hormone Drugs Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Human Growth Hormone Drugs by Country
7.1.1 Europe Human Growth Hormone Drugs Sales by Country (2020-2025)
7.1.2 Europe Human Growth Hormone Drugs Revenue by Country (2020-2025)
7.2 Europe Human Growth Hormone Drugs Sales by Type (2020-2025)
7.3 Europe Human Growth Hormone Drugs Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Human Growth Hormone Drugs by Country
8.1.1 Middle East & Africa Human Growth Hormone Drugs Sales by Country (2020-2025)
8.1.2 Middle East & Africa Human Growth Hormone Drugs Revenue by Country (2020-2025)
8.2 Middle East & Africa Human Growth Hormone Drugs Sales by Type (2020-2025)
8.3 Middle East & Africa Human Growth Hormone Drugs Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Human Growth Hormone Drugs
10.3 Manufacturing Process Analysis of Human Growth Hormone Drugs
10.4 Industry Chain Structure of Human Growth Hormone Drugs
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Human Growth Hormone Drugs Distributors
11.3 Human Growth Hormone Drugs Customer
12 WORLD FORECAST REVIEW FOR HUMAN GROWTH HORMONE DRUGS BY GEOGRAPHIC REGION
12.1 Global Human Growth Hormone Drugs Market Size Forecast by Region
12.1.1 Global Human Growth Hormone Drugs Forecast by Region (2026-2031)
12.1.2 Global Human Growth Hormone Drugs Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Human Growth Hormone Drugs Forecast by Type (2026-2031)
12.7 Global Human Growth Hormone Drugs Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Eli Lilly and Company (US)
13.1.1 Eli Lilly and Company (US) Company Information
13.1.2 Eli Lilly and Company (US) Human Growth Hormone Drugs Product Portfolios and Specifications
13.1.3 Eli Lilly and Company (US) Human Growth Hormone Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Eli Lilly and Company (US) Main Business Overview
13.1.5 Eli Lilly and Company (US) Latest Developments
13.2 Ferring Holding SA (Switzerland)
13.2.1 Ferring Holding SA (Switzerland) Company Information
13.2.2 Ferring Holding SA (Switzerland) Human Growth Hormone Drugs Product Portfolios and Specifications
13.2.3 Ferring Holding SA (Switzerland) Human Growth Hormone Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Ferring Holding SA (Switzerland) Main Business Overview
13.2.5 Ferring Holding SA (Switzerland) Latest Developments
13.3 Genentech, Inc. (US)
13.3.1 Genentech, Inc. (US) Company Information
13.3.2 Genentech, Inc. (US) Human Growth Hormone Drugs Product Portfolios and Specifications
13.3.3 Genentech, Inc. (US) Human Growth Hormone Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Genentech, Inc. (US) Main Business Overview
13.3.5 Genentech, Inc. (US) Latest Developments
13.4 GeneScience Pharmaceuticals Co., Ltd. (China)
13.4.1 GeneScience Pharmaceuticals Co., Ltd. (China) Company Information
13.4.2 GeneScience Pharmaceuticals Co., Ltd. (China) Human Growth Hormone Drugs Product Portfolios and Specifications
13.4.3 GeneScience Pharmaceuticals Co., Ltd. (China) Human Growth Hormone Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 GeneScience Pharmaceuticals Co., Ltd. (China) Main Business Overview
13.4.5 GeneScience Pharmaceuticals Co., Ltd. (China) Latest Developments
13.5 Merck KgaA (Germany)
13.5.1 Merck KgaA (Germany) Company Information
13.5.2 Merck KgaA (Germany) Human Growth Hormone Drugs Product Portfolios and Specifications
13.5.3 Merck KgaA (Germany) Human Growth Hormone Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Merck KgaA (Germany) Main Business Overview
13.5.5 Merck KgaA (Germany) Latest Developments
13.6 Novo Nordisk A/S (Denmark)
13.6.1 Novo Nordisk A/S (Denmark) Company Information
13.6.2 Novo Nordisk A/S (Denmark) Human Growth Hormone Drugs Product Portfolios and Specifications
13.6.3 Novo Nordisk A/S (Denmark) Human Growth Hormone Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Novo Nordisk A/S (Denmark) Main Business Overview
13.6.5 Novo Nordisk A/S (Denmark) Latest Developments
13.7 Pfizer, Inc. (US)
13.7.1 Pfizer, Inc. (US) Company Information
13.7.2 Pfizer, Inc. (US) Human Growth Hormone Drugs Product Portfolios and Specifications
13.7.3 Pfizer, Inc. (US) Human Growth Hormone Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Pfizer, Inc. (US) Main Business Overview
13.7.5 Pfizer, Inc. (US) Latest Developments
13.8 Sandoz International GmbH (Germany)
13.8.1 Sandoz International GmbH (Germany) Company Information
13.8.2 Sandoz International GmbH (Germany) Human Growth Hormone Drugs Product Portfolios and Specifications
13.8.3 Sandoz International GmbH (Germany) Human Growth Hormone Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Sandoz International GmbH (Germany) Main Business Overview
13.8.5 Sandoz International GmbH (Germany) Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Human Growth Hormone Drugs Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Human Growth Hormone Drugs by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Human Growth Hormone Drugs by Country/Region, 2020, 2024 & 2031
2.2 Human Growth Hormone Drugs Segment by Type
2.2.1 Norditropin
2.2.2 Genotropin
2.2.3 Humatrope
2.2.4 Saizen
2.2.5 Omnitrope - the Somatropin Biosimilar
2.2.6 Somatropin Biopartners
2.3 Human Growth Hormone Drugs Sales by Type
2.3.1 Global Human Growth Hormone Drugs Sales Market Share by Type (2020-2025)
2.3.2 Global Human Growth Hormone Drugs Revenue and Market Share by Type (2020-2025)
2.3.3 Global Human Growth Hormone Drugs Sale Price by Type (2020-2025)
2.4 Human Growth Hormone Drugs Segment by Application
2.4.1 Prader-Willi Syndrome
2.4.2 Turner Syndrome
2.4.3 Short Stature Homeobox Gene
2.4.4 Small for Gestational Age
2.4.5 Chronic Renal Insufficiency
2.4.6 Short Bowel Syndrome
2.5 Human Growth Hormone Drugs Sales by Application
2.5.1 Global Human Growth Hormone Drugs Sale Market Share by Application (2020-2025)
2.5.2 Global Human Growth Hormone Drugs Revenue and Market Share by Application (2020-2025)
2.5.3 Global Human Growth Hormone Drugs Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Human Growth Hormone Drugs Breakdown Data by Company
3.1.1 Global Human Growth Hormone Drugs Annual Sales by Company (2020-2025)
3.1.2 Global Human Growth Hormone Drugs Sales Market Share by Company (2020-2025)
3.2 Global Human Growth Hormone Drugs Annual Revenue by Company (2020-2025)
3.2.1 Global Human Growth Hormone Drugs Revenue by Company (2020-2025)
3.2.2 Global Human Growth Hormone Drugs Revenue Market Share by Company (2020-2025)
3.3 Global Human Growth Hormone Drugs Sale Price by Company
3.4 Key Manufacturers Human Growth Hormone Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Human Growth Hormone Drugs Product Location Distribution
3.4.2 Players Human Growth Hormone Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR HUMAN GROWTH HORMONE DRUGS BY GEOGRAPHIC REGION
4.1 World Historic Human Growth Hormone Drugs Market Size by Geographic Region (2020-2025)
4.1.1 Global Human Growth Hormone Drugs Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Human Growth Hormone Drugs Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Human Growth Hormone Drugs Market Size by Country/Region (2020-2025)
4.2.1 Global Human Growth Hormone Drugs Annual Sales by Country/Region (2020-2025)
4.2.2 Global Human Growth Hormone Drugs Annual Revenue by Country/Region (2020-2025)
4.3 Americas Human Growth Hormone Drugs Sales Growth
4.4 APAC Human Growth Hormone Drugs Sales Growth
4.5 Europe Human Growth Hormone Drugs Sales Growth
4.6 Middle East & Africa Human Growth Hormone Drugs Sales Growth
5 AMERICAS
5.1 Americas Human Growth Hormone Drugs Sales by Country
5.1.1 Americas Human Growth Hormone Drugs Sales by Country (2020-2025)
5.1.2 Americas Human Growth Hormone Drugs Revenue by Country (2020-2025)
5.2 Americas Human Growth Hormone Drugs Sales by Type (2020-2025)
5.3 Americas Human Growth Hormone Drugs Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Human Growth Hormone Drugs Sales by Region
6.1.1 APAC Human Growth Hormone Drugs Sales by Region (2020-2025)
6.1.2 APAC Human Growth Hormone Drugs Revenue by Region (2020-2025)
6.2 APAC Human Growth Hormone Drugs Sales by Type (2020-2025)
6.3 APAC Human Growth Hormone Drugs Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Human Growth Hormone Drugs by Country
7.1.1 Europe Human Growth Hormone Drugs Sales by Country (2020-2025)
7.1.2 Europe Human Growth Hormone Drugs Revenue by Country (2020-2025)
7.2 Europe Human Growth Hormone Drugs Sales by Type (2020-2025)
7.3 Europe Human Growth Hormone Drugs Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Human Growth Hormone Drugs by Country
8.1.1 Middle East & Africa Human Growth Hormone Drugs Sales by Country (2020-2025)
8.1.2 Middle East & Africa Human Growth Hormone Drugs Revenue by Country (2020-2025)
8.2 Middle East & Africa Human Growth Hormone Drugs Sales by Type (2020-2025)
8.3 Middle East & Africa Human Growth Hormone Drugs Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Human Growth Hormone Drugs
10.3 Manufacturing Process Analysis of Human Growth Hormone Drugs
10.4 Industry Chain Structure of Human Growth Hormone Drugs
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Human Growth Hormone Drugs Distributors
11.3 Human Growth Hormone Drugs Customer
12 WORLD FORECAST REVIEW FOR HUMAN GROWTH HORMONE DRUGS BY GEOGRAPHIC REGION
12.1 Global Human Growth Hormone Drugs Market Size Forecast by Region
12.1.1 Global Human Growth Hormone Drugs Forecast by Region (2026-2031)
12.1.2 Global Human Growth Hormone Drugs Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Human Growth Hormone Drugs Forecast by Type (2026-2031)
12.7 Global Human Growth Hormone Drugs Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Eli Lilly and Company (US)
13.1.1 Eli Lilly and Company (US) Company Information
13.1.2 Eli Lilly and Company (US) Human Growth Hormone Drugs Product Portfolios and Specifications
13.1.3 Eli Lilly and Company (US) Human Growth Hormone Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Eli Lilly and Company (US) Main Business Overview
13.1.5 Eli Lilly and Company (US) Latest Developments
13.2 Ferring Holding SA (Switzerland)
13.2.1 Ferring Holding SA (Switzerland) Company Information
13.2.2 Ferring Holding SA (Switzerland) Human Growth Hormone Drugs Product Portfolios and Specifications
13.2.3 Ferring Holding SA (Switzerland) Human Growth Hormone Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Ferring Holding SA (Switzerland) Main Business Overview
13.2.5 Ferring Holding SA (Switzerland) Latest Developments
13.3 Genentech, Inc. (US)
13.3.1 Genentech, Inc. (US) Company Information
13.3.2 Genentech, Inc. (US) Human Growth Hormone Drugs Product Portfolios and Specifications
13.3.3 Genentech, Inc. (US) Human Growth Hormone Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Genentech, Inc. (US) Main Business Overview
13.3.5 Genentech, Inc. (US) Latest Developments
13.4 GeneScience Pharmaceuticals Co., Ltd. (China)
13.4.1 GeneScience Pharmaceuticals Co., Ltd. (China) Company Information
13.4.2 GeneScience Pharmaceuticals Co., Ltd. (China) Human Growth Hormone Drugs Product Portfolios and Specifications
13.4.3 GeneScience Pharmaceuticals Co., Ltd. (China) Human Growth Hormone Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 GeneScience Pharmaceuticals Co., Ltd. (China) Main Business Overview
13.4.5 GeneScience Pharmaceuticals Co., Ltd. (China) Latest Developments
13.5 Merck KgaA (Germany)
13.5.1 Merck KgaA (Germany) Company Information
13.5.2 Merck KgaA (Germany) Human Growth Hormone Drugs Product Portfolios and Specifications
13.5.3 Merck KgaA (Germany) Human Growth Hormone Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Merck KgaA (Germany) Main Business Overview
13.5.5 Merck KgaA (Germany) Latest Developments
13.6 Novo Nordisk A/S (Denmark)
13.6.1 Novo Nordisk A/S (Denmark) Company Information
13.6.2 Novo Nordisk A/S (Denmark) Human Growth Hormone Drugs Product Portfolios and Specifications
13.6.3 Novo Nordisk A/S (Denmark) Human Growth Hormone Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Novo Nordisk A/S (Denmark) Main Business Overview
13.6.5 Novo Nordisk A/S (Denmark) Latest Developments
13.7 Pfizer, Inc. (US)
13.7.1 Pfizer, Inc. (US) Company Information
13.7.2 Pfizer, Inc. (US) Human Growth Hormone Drugs Product Portfolios and Specifications
13.7.3 Pfizer, Inc. (US) Human Growth Hormone Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Pfizer, Inc. (US) Main Business Overview
13.7.5 Pfizer, Inc. (US) Latest Developments
13.8 Sandoz International GmbH (Germany)
13.8.1 Sandoz International GmbH (Germany) Company Information
13.8.2 Sandoz International GmbH (Germany) Human Growth Hormone Drugs Product Portfolios and Specifications
13.8.3 Sandoz International GmbH (Germany) Human Growth Hormone Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Sandoz International GmbH (Germany) Main Business Overview
13.8.5 Sandoz International GmbH (Germany) Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Human Growth Hormone Drugs Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Human Growth Hormone Drugs Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Norditropin
Table 4. Major Players of Genotropin
Table 5. Major Players of Humatrope
Table 6. Major Players of Saizen
Table 7. Major Players of Omnitrope - the Somatropin Biosimilar
Table 8. Major Players of Somatropin Biopartners
Table 9. Global Human Growth Hormone Drugs Sales by Type (2020-2025) & (K Pcs)
Table 10. Global Human Growth Hormone Drugs Sales Market Share by Type (2020-2025)
Table 11. Global Human Growth Hormone Drugs Revenue by Type (2020-2025) & ($ million)
Table 12. Global Human Growth Hormone Drugs Revenue Market Share by Type (2020-2025)
Table 13. Global Human Growth Hormone Drugs Sale Price by Type (2020-2025) & (USD/Pcs)
Table 14. Global Human Growth Hormone Drugs Sale by Application (2020-2025) & (K Pcs)
Table 15. Global Human Growth Hormone Drugs Sale Market Share by Application (2020-2025)
Table 16. Global Human Growth Hormone Drugs Revenue by Application (2020-2025) & ($ million)
Table 17. Global Human Growth Hormone Drugs Revenue Market Share by Application (2020-2025)
Table 18. Global Human Growth Hormone Drugs Sale Price by Application (2020-2025) & (USD/Pcs)
Table 19. Global Human Growth Hormone Drugs Sales by Company (2020-2025) & (K Pcs)
Table 20. Global Human Growth Hormone Drugs Sales Market Share by Company (2020-2025)
Table 21. Global Human Growth Hormone Drugs Revenue by Company (2020-2025) & ($ millions)
Table 22. Global Human Growth Hormone Drugs Revenue Market Share by Company (2020-2025)
Table 23. Global Human Growth Hormone Drugs Sale Price by Company (2020-2025) & (USD/Pcs)
Table 24. Key Manufacturers Human Growth Hormone Drugs Producing Area Distribution and Sales Area
Table 25. Players Human Growth Hormone Drugs Products Offered
Table 26. Human Growth Hormone Drugs Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 27. New Products and Potential Entrants
Table 28. Market M&A Activity & Strategy
Table 29. Global Human Growth Hormone Drugs Sales by Geographic Region (2020-2025) & (K Pcs)
Table 30. Global Human Growth Hormone Drugs Sales Market Share Geographic Region (2020-2025)
Table 31. Global Human Growth Hormone Drugs Revenue by Geographic Region (2020-2025) & ($ millions)
Table 32. Global Human Growth Hormone Drugs Revenue Market Share by Geographic Region (2020-2025)
Table 33. Global Human Growth Hormone Drugs Sales by Country/Region (2020-2025) & (K Pcs)
Table 34. Global Human Growth Hormone Drugs Sales Market Share by Country/Region (2020-2025)
Table 35. Global Human Growth Hormone Drugs Revenue by Country/Region (2020-2025) & ($ millions)
Table 36. Global Human Growth Hormone Drugs Revenue Market Share by Country/Region (2020-2025)
Table 37. Americas Human Growth Hormone Drugs Sales by Country (2020-2025) & (K Pcs)
Table 38. Americas Human Growth Hormone Drugs Sales Market Share by Country (2020-2025)
Table 39. Americas Human Growth Hormone Drugs Revenue by Country (2020-2025) & ($ millions)
Table 40. Americas Human Growth Hormone Drugs Sales by Type (2020-2025) & (K Pcs)
Table 41. Americas Human Growth Hormone Drugs Sales by Application (2020-2025) & (K Pcs)
Table 42. APAC Human Growth Hormone Drugs Sales by Region (2020-2025) & (K Pcs)
Table 43. APAC Human Growth Hormone Drugs Sales Market Share by Region (2020-2025)
Table 44. APAC Human Growth Hormone Drugs Revenue by Region (2020-2025) & ($ millions)
Table 45. APAC Human Growth Hormone Drugs Sales by Type (2020-2025) & (K Pcs)
Table 46. APAC Human Growth Hormone Drugs Sales by Application (2020-2025) & (K Pcs)
Table 47. Europe Human Growth Hormone Drugs Sales by Country (2020-2025) & (K Pcs)
Table 48. Europe Human Growth Hormone Drugs Revenue by Country (2020-2025) & ($ millions)
Table 49. Europe Human Growth Hormone Drugs Sales by Type (2020-2025) & (K Pcs)
Table 50. Europe Human Growth Hormone Drugs Sales by Application (2020-2025) & (K Pcs)
Table 51. Middle East & Africa Human Growth Hormone Drugs Sales by Country (2020-2025) & (K Pcs)
Table 52. Middle East & Africa Human Growth Hormone Drugs Revenue Market Share by Country (2020-2025)
Table 53. Middle East & Africa Human Growth Hormone Drugs Sales by Type (2020-2025) & (K Pcs)
Table 54. Middle East & Africa Human Growth Hormone Drugs Sales by Application (2020-2025) & (K Pcs)
Table 55. Key Market Drivers & Growth Opportunities of Human Growth Hormone Drugs
Table 56. Key Market Challenges & Risks of Human Growth Hormone Drugs
Table 57. Key Industry Trends of Human Growth Hormone Drugs
Table 58. Human Growth Hormone Drugs Raw Material
Table 59. Key Suppliers of Raw Materials
Table 60. Human Growth Hormone Drugs Distributors List
Table 61. Human Growth Hormone Drugs Customer List
Table 62. Global Human Growth Hormone Drugs Sales Forecast by Region (2026-2031) & (K Pcs)
Table 63. Global Human Growth Hormone Drugs Revenue Forecast by Region (2026-2031) & ($ millions)
Table 64. Americas Human Growth Hormone Drugs Sales Forecast by Country (2026-2031) & (K Pcs)
Table 65. Americas Human Growth Hormone Drugs Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 66. APAC Human Growth Hormone Drugs Sales Forecast by Region (2026-2031) & (K Pcs)
Table 67. APAC Human Growth Hormone Drugs Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 68. Europe Human Growth Hormone Drugs Sales Forecast by Country (2026-2031) & (K Pcs)
Table 69. Europe Human Growth Hormone Drugs Revenue Forecast by Country (2026-2031) & ($ millions)
Table 70. Middle East & Africa Human Growth Hormone Drugs Sales Forecast by Country (2026-2031) & (K Pcs)
Table 71. Middle East & Africa Human Growth Hormone Drugs Revenue Forecast by Country (2026-2031) & ($ millions)
Table 72. Global Human Growth Hormone Drugs Sales Forecast by Type (2026-2031) & (K Pcs)
Table 73. Global Human Growth Hormone Drugs Revenue Forecast by Type (2026-2031) & ($ millions)
Table 74. Global Human Growth Hormone Drugs Sales Forecast by Application (2026-2031) & (K Pcs)
Table 75. Global Human Growth Hormone Drugs Revenue Forecast by Application (2026-2031) & ($ millions)
Table 76. Eli Lilly and Company (US) Basic Information, Human Growth Hormone Drugs Manufacturing Base, Sales Area and Its Competitors
Table 77. Eli Lilly and Company (US) Human Growth Hormone Drugs Product Portfolios and Specifications
Table 78. Eli Lilly and Company (US) Human Growth Hormone Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 79. Eli Lilly and Company (US) Main Business
Table 80. Eli Lilly and Company (US) Latest Developments
Table 81. Ferring Holding SA (Switzerland) Basic Information, Human Growth Hormone Drugs Manufacturing Base, Sales Area and Its Competitors
Table 82. Ferring Holding SA (Switzerland) Human Growth Hormone Drugs Product Portfolios and Specifications
Table 83. Ferring Holding SA (Switzerland) Human Growth Hormone Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 84. Ferring Holding SA (Switzerland) Main Business
Table 85. Ferring Holding SA (Switzerland) Latest Developments
Table 86. Genentech, Inc. (US) Basic Information, Human Growth Hormone Drugs Manufacturing Base, Sales Area and Its Competitors
Table 87. Genentech, Inc. (US) Human Growth Hormone Drugs Product Portfolios and Specifications
Table 88. Genentech, Inc. (US) Human Growth Hormone Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 89. Genentech, Inc. (US) Main Business
Table 90. Genentech, Inc. (US) Latest Developments
Table 91. GeneScience Pharmaceuticals Co., Ltd. (China) Basic Information, Human Growth Hormone Drugs Manufacturing Base, Sales Area and Its Competitors
Table 92. GeneScience Pharmaceuticals Co., Ltd. (China) Human Growth Hormone Drugs Product Portfolios and Specifications
Table 93. GeneScience Pharmaceuticals Co., Ltd. (China) Human Growth Hormone Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 94. GeneScience Pharmaceuticals Co., Ltd. (China) Main Business
Table 95. GeneScience Pharmaceuticals Co., Ltd. (China) Latest Developments
Table 96. Merck KgaA (Germany) Basic Information, Human Growth Hormone Drugs Manufacturing Base, Sales Area and Its Competitors
Table 97. Merck KgaA (Germany) Human Growth Hormone Drugs Product Portfolios and Specifications
Table 98. Merck KgaA (Germany) Human Growth Hormone Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 99. Merck KgaA (Germany) Main Business
Table 100. Merck KgaA (Germany) Latest Developments
Table 101. Novo Nordisk A/S (Denmark) Basic Information, Human Growth Hormone Drugs Manufacturing Base, Sales Area and Its Competitors
Table 102. Novo Nordisk A/S (Denmark) Human Growth Hormone Drugs Product Portfolios and Specifications
Table 103. Novo Nordisk A/S (Denmark) Human Growth Hormone Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 104. Novo Nordisk A/S (Denmark) Main Business
Table 105. Novo Nordisk A/S (Denmark) Latest Developments
Table 106. Pfizer, Inc. (US) Basic Information, Human Growth Hormone Drugs Manufacturing Base, Sales Area and Its Competitors
Table 107. Pfizer, Inc. (US) Human Growth Hormone Drugs Product Portfolios and Specifications
Table 108. Pfizer, Inc. (US) Human Growth Hormone Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 109. Pfizer, Inc. (US) Main Business
Table 110. Pfizer, Inc. (US) Latest Developments
Table 111. Sandoz International GmbH (Germany) Basic Information, Human Growth Hormone Drugs Manufacturing Base, Sales Area and Its Competitors
Table 112. Sandoz International GmbH (Germany) Human Growth Hormone Drugs Product Portfolios and Specifications
Table 113. Sandoz International GmbH (Germany) Human Growth Hormone Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 114. Sandoz International GmbH (Germany) Main Business
Table 115. Sandoz International GmbH (Germany) Latest Developments
Table 1. Human Growth Hormone Drugs Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Human Growth Hormone Drugs Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Norditropin
Table 4. Major Players of Genotropin
Table 5. Major Players of Humatrope
Table 6. Major Players of Saizen
Table 7. Major Players of Omnitrope - the Somatropin Biosimilar
Table 8. Major Players of Somatropin Biopartners
Table 9. Global Human Growth Hormone Drugs Sales by Type (2020-2025) & (K Pcs)
Table 10. Global Human Growth Hormone Drugs Sales Market Share by Type (2020-2025)
Table 11. Global Human Growth Hormone Drugs Revenue by Type (2020-2025) & ($ million)
Table 12. Global Human Growth Hormone Drugs Revenue Market Share by Type (2020-2025)
Table 13. Global Human Growth Hormone Drugs Sale Price by Type (2020-2025) & (USD/Pcs)
Table 14. Global Human Growth Hormone Drugs Sale by Application (2020-2025) & (K Pcs)
Table 15. Global Human Growth Hormone Drugs Sale Market Share by Application (2020-2025)
Table 16. Global Human Growth Hormone Drugs Revenue by Application (2020-2025) & ($ million)
Table 17. Global Human Growth Hormone Drugs Revenue Market Share by Application (2020-2025)
Table 18. Global Human Growth Hormone Drugs Sale Price by Application (2020-2025) & (USD/Pcs)
Table 19. Global Human Growth Hormone Drugs Sales by Company (2020-2025) & (K Pcs)
Table 20. Global Human Growth Hormone Drugs Sales Market Share by Company (2020-2025)
Table 21. Global Human Growth Hormone Drugs Revenue by Company (2020-2025) & ($ millions)
Table 22. Global Human Growth Hormone Drugs Revenue Market Share by Company (2020-2025)
Table 23. Global Human Growth Hormone Drugs Sale Price by Company (2020-2025) & (USD/Pcs)
Table 24. Key Manufacturers Human Growth Hormone Drugs Producing Area Distribution and Sales Area
Table 25. Players Human Growth Hormone Drugs Products Offered
Table 26. Human Growth Hormone Drugs Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 27. New Products and Potential Entrants
Table 28. Market M&A Activity & Strategy
Table 29. Global Human Growth Hormone Drugs Sales by Geographic Region (2020-2025) & (K Pcs)
Table 30. Global Human Growth Hormone Drugs Sales Market Share Geographic Region (2020-2025)
Table 31. Global Human Growth Hormone Drugs Revenue by Geographic Region (2020-2025) & ($ millions)
Table 32. Global Human Growth Hormone Drugs Revenue Market Share by Geographic Region (2020-2025)
Table 33. Global Human Growth Hormone Drugs Sales by Country/Region (2020-2025) & (K Pcs)
Table 34. Global Human Growth Hormone Drugs Sales Market Share by Country/Region (2020-2025)
Table 35. Global Human Growth Hormone Drugs Revenue by Country/Region (2020-2025) & ($ millions)
Table 36. Global Human Growth Hormone Drugs Revenue Market Share by Country/Region (2020-2025)
Table 37. Americas Human Growth Hormone Drugs Sales by Country (2020-2025) & (K Pcs)
Table 38. Americas Human Growth Hormone Drugs Sales Market Share by Country (2020-2025)
Table 39. Americas Human Growth Hormone Drugs Revenue by Country (2020-2025) & ($ millions)
Table 40. Americas Human Growth Hormone Drugs Sales by Type (2020-2025) & (K Pcs)
Table 41. Americas Human Growth Hormone Drugs Sales by Application (2020-2025) & (K Pcs)
Table 42. APAC Human Growth Hormone Drugs Sales by Region (2020-2025) & (K Pcs)
Table 43. APAC Human Growth Hormone Drugs Sales Market Share by Region (2020-2025)
Table 44. APAC Human Growth Hormone Drugs Revenue by Region (2020-2025) & ($ millions)
Table 45. APAC Human Growth Hormone Drugs Sales by Type (2020-2025) & (K Pcs)
Table 46. APAC Human Growth Hormone Drugs Sales by Application (2020-2025) & (K Pcs)
Table 47. Europe Human Growth Hormone Drugs Sales by Country (2020-2025) & (K Pcs)
Table 48. Europe Human Growth Hormone Drugs Revenue by Country (2020-2025) & ($ millions)
Table 49. Europe Human Growth Hormone Drugs Sales by Type (2020-2025) & (K Pcs)
Table 50. Europe Human Growth Hormone Drugs Sales by Application (2020-2025) & (K Pcs)
Table 51. Middle East & Africa Human Growth Hormone Drugs Sales by Country (2020-2025) & (K Pcs)
Table 52. Middle East & Africa Human Growth Hormone Drugs Revenue Market Share by Country (2020-2025)
Table 53. Middle East & Africa Human Growth Hormone Drugs Sales by Type (2020-2025) & (K Pcs)
Table 54. Middle East & Africa Human Growth Hormone Drugs Sales by Application (2020-2025) & (K Pcs)
Table 55. Key Market Drivers & Growth Opportunities of Human Growth Hormone Drugs
Table 56. Key Market Challenges & Risks of Human Growth Hormone Drugs
Table 57. Key Industry Trends of Human Growth Hormone Drugs
Table 58. Human Growth Hormone Drugs Raw Material
Table 59. Key Suppliers of Raw Materials
Table 60. Human Growth Hormone Drugs Distributors List
Table 61. Human Growth Hormone Drugs Customer List
Table 62. Global Human Growth Hormone Drugs Sales Forecast by Region (2026-2031) & (K Pcs)
Table 63. Global Human Growth Hormone Drugs Revenue Forecast by Region (2026-2031) & ($ millions)
Table 64. Americas Human Growth Hormone Drugs Sales Forecast by Country (2026-2031) & (K Pcs)
Table 65. Americas Human Growth Hormone Drugs Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 66. APAC Human Growth Hormone Drugs Sales Forecast by Region (2026-2031) & (K Pcs)
Table 67. APAC Human Growth Hormone Drugs Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 68. Europe Human Growth Hormone Drugs Sales Forecast by Country (2026-2031) & (K Pcs)
Table 69. Europe Human Growth Hormone Drugs Revenue Forecast by Country (2026-2031) & ($ millions)
Table 70. Middle East & Africa Human Growth Hormone Drugs Sales Forecast by Country (2026-2031) & (K Pcs)
Table 71. Middle East & Africa Human Growth Hormone Drugs Revenue Forecast by Country (2026-2031) & ($ millions)
Table 72. Global Human Growth Hormone Drugs Sales Forecast by Type (2026-2031) & (K Pcs)
Table 73. Global Human Growth Hormone Drugs Revenue Forecast by Type (2026-2031) & ($ millions)
Table 74. Global Human Growth Hormone Drugs Sales Forecast by Application (2026-2031) & (K Pcs)
Table 75. Global Human Growth Hormone Drugs Revenue Forecast by Application (2026-2031) & ($ millions)
Table 76. Eli Lilly and Company (US) Basic Information, Human Growth Hormone Drugs Manufacturing Base, Sales Area and Its Competitors
Table 77. Eli Lilly and Company (US) Human Growth Hormone Drugs Product Portfolios and Specifications
Table 78. Eli Lilly and Company (US) Human Growth Hormone Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 79. Eli Lilly and Company (US) Main Business
Table 80. Eli Lilly and Company (US) Latest Developments
Table 81. Ferring Holding SA (Switzerland) Basic Information, Human Growth Hormone Drugs Manufacturing Base, Sales Area and Its Competitors
Table 82. Ferring Holding SA (Switzerland) Human Growth Hormone Drugs Product Portfolios and Specifications
Table 83. Ferring Holding SA (Switzerland) Human Growth Hormone Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 84. Ferring Holding SA (Switzerland) Main Business
Table 85. Ferring Holding SA (Switzerland) Latest Developments
Table 86. Genentech, Inc. (US) Basic Information, Human Growth Hormone Drugs Manufacturing Base, Sales Area and Its Competitors
Table 87. Genentech, Inc. (US) Human Growth Hormone Drugs Product Portfolios and Specifications
Table 88. Genentech, Inc. (US) Human Growth Hormone Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 89. Genentech, Inc. (US) Main Business
Table 90. Genentech, Inc. (US) Latest Developments
Table 91. GeneScience Pharmaceuticals Co., Ltd. (China) Basic Information, Human Growth Hormone Drugs Manufacturing Base, Sales Area and Its Competitors
Table 92. GeneScience Pharmaceuticals Co., Ltd. (China) Human Growth Hormone Drugs Product Portfolios and Specifications
Table 93. GeneScience Pharmaceuticals Co., Ltd. (China) Human Growth Hormone Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 94. GeneScience Pharmaceuticals Co., Ltd. (China) Main Business
Table 95. GeneScience Pharmaceuticals Co., Ltd. (China) Latest Developments
Table 96. Merck KgaA (Germany) Basic Information, Human Growth Hormone Drugs Manufacturing Base, Sales Area and Its Competitors
Table 97. Merck KgaA (Germany) Human Growth Hormone Drugs Product Portfolios and Specifications
Table 98. Merck KgaA (Germany) Human Growth Hormone Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 99. Merck KgaA (Germany) Main Business
Table 100. Merck KgaA (Germany) Latest Developments
Table 101. Novo Nordisk A/S (Denmark) Basic Information, Human Growth Hormone Drugs Manufacturing Base, Sales Area and Its Competitors
Table 102. Novo Nordisk A/S (Denmark) Human Growth Hormone Drugs Product Portfolios and Specifications
Table 103. Novo Nordisk A/S (Denmark) Human Growth Hormone Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 104. Novo Nordisk A/S (Denmark) Main Business
Table 105. Novo Nordisk A/S (Denmark) Latest Developments
Table 106. Pfizer, Inc. (US) Basic Information, Human Growth Hormone Drugs Manufacturing Base, Sales Area and Its Competitors
Table 107. Pfizer, Inc. (US) Human Growth Hormone Drugs Product Portfolios and Specifications
Table 108. Pfizer, Inc. (US) Human Growth Hormone Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 109. Pfizer, Inc. (US) Main Business
Table 110. Pfizer, Inc. (US) Latest Developments
Table 111. Sandoz International GmbH (Germany) Basic Information, Human Growth Hormone Drugs Manufacturing Base, Sales Area and Its Competitors
Table 112. Sandoz International GmbH (Germany) Human Growth Hormone Drugs Product Portfolios and Specifications
Table 113. Sandoz International GmbH (Germany) Human Growth Hormone Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 114. Sandoz International GmbH (Germany) Main Business
Table 115. Sandoz International GmbH (Germany) Latest Developments
LIST OF FIGURES
Figure 1. Picture of Human Growth Hormone Drugs
Figure 2. Human Growth Hormone Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Human Growth Hormone Drugs Sales Growth Rate 2020-2031 (K Pcs)
Figure 7. Global Human Growth Hormone Drugs Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Human Growth Hormone Drugs Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Human Growth Hormone Drugs Sales Market Share by Country/Region (2024)
Figure 10. Human Growth Hormone Drugs Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Norditropin
Figure 12. Product Picture of Genotropin
Figure 13. Product Picture of Humatrope
Figure 14. Product Picture of Saizen
Figure 15. Product Picture of Omnitrope - the Somatropin Biosimilar
Figure 16. Product Picture of Somatropin Biopartners
Figure 17. Global Human Growth Hormone Drugs Sales Market Share by Type in 2025
Figure 18. Global Human Growth Hormone Drugs Revenue Market Share by Type (2020-2025)
Figure 19. Human Growth Hormone Drugs Consumed in Prader-Willi Syndrome
Figure 20. Global Human Growth Hormone Drugs Market: Prader-Willi Syndrome (2020-2025) & (K Pcs)
Figure 21. Human Growth Hormone Drugs Consumed in Turner Syndrome
Figure 22. Global Human Growth Hormone Drugs Market: Turner Syndrome (2020-2025) & (K Pcs)
Figure 23. Human Growth Hormone Drugs Consumed in Short Stature Homeobox Gene
Figure 24. Global Human Growth Hormone Drugs Market: Short Stature Homeobox Gene (2020-2025) & (K Pcs)
Figure 25. Human Growth Hormone Drugs Consumed in Small for Gestational Age
Figure 26. Global Human Growth Hormone Drugs Market: Small for Gestational Age (2020-2025) & (K Pcs)
Figure 27. Human Growth Hormone Drugs Consumed in Chronic Renal Insufficiency
Figure 28. Global Human Growth Hormone Drugs Market: Chronic Renal Insufficiency (2020-2025) & (K Pcs)
Figure 29. Human Growth Hormone Drugs Consumed in Short Bowel Syndrome
Figure 30. Global Human Growth Hormone Drugs Market: Short Bowel Syndrome (2020-2025) & (K Pcs)
Figure 31. Global Human Growth Hormone Drugs Sale Market Share by Application (2024)
Figure 32. Global Human Growth Hormone Drugs Revenue Market Share by Application in 2025
Figure 33. Human Growth Hormone Drugs Sales by Company in 2025 (K Pcs)
Figure 34. Global Human Growth Hormone Drugs Sales Market Share by Company in 2025
Figure 35. Human Growth Hormone Drugs Revenue by Company in 2025 ($ millions)
Figure 36. Global Human Growth Hormone Drugs Revenue Market Share by Company in 2025
Figure 37. Global Human Growth Hormone Drugs Sales Market Share by Geographic Region (2020-2025)
Figure 38. Global Human Growth Hormone Drugs Revenue Market Share by Geographic Region in 2025
Figure 39. Americas Human Growth Hormone Drugs Sales 2020-2025 (K Pcs)
Figure 40. Americas Human Growth Hormone Drugs Revenue 2020-2025 ($ millions)
Figure 41. APAC Human Growth Hormone Drugs Sales 2020-2025 (K Pcs)
Figure 42. APAC Human Growth Hormone Drugs Revenue 2020-2025 ($ millions)
Figure 43. Europe Human Growth Hormone Drugs Sales 2020-2025 (K Pcs)
Figure 44. Europe Human Growth Hormone Drugs Revenue 2020-2025 ($ millions)
Figure 45. Middle East & Africa Human Growth Hormone Drugs Sales 2020-2025 (K Pcs)
Figure 46. Middle East & Africa Human Growth Hormone Drugs Revenue 2020-2025 ($ millions)
Figure 47. Americas Human Growth Hormone Drugs Sales Market Share by Country in 2025
Figure 48. Americas Human Growth Hormone Drugs Revenue Market Share by Country (2020-2025)
Figure 49. Americas Human Growth Hormone Drugs Sales Market Share by Type (2020-2025)
Figure 50. Americas Human Growth Hormone Drugs Sales Market Share by Application (2020-2025)
Figure 51. United States Human Growth Hormone Drugs Revenue Growth 2020-2025 ($ millions)
Figure 52. Canada Human Growth Hormone Drugs Revenue Growth 2020-2025 ($ millions)
Figure 53. Mexico Human Growth Hormone Drugs Revenue Growth 2020-2025 ($ millions)
Figure 54. Brazil Human Growth Hormone Drugs Revenue Growth 2020-2025 ($ millions)
Figure 55. APAC Human Growth Hormone Drugs Sales Market Share by Region in 2025
Figure 56. APAC Human Growth Hormone Drugs Revenue Market Share by Region (2020-2025)
Figure 57. APAC Human Growth Hormone Drugs Sales Market Share by Type (2020-2025)
Figure 58. APAC Human Growth Hormone Drugs Sales Market Share by Application (2020-2025)
Figure 59. China Human Growth Hormone Drugs Revenue Growth 2020-2025 ($ millions)
Figure 60. Japan Human Growth Hormone Drugs Revenue Growth 2020-2025 ($ millions)
Figure 61. South Korea Human Growth Hormone Drugs Revenue Growth 2020-2025 ($ millions)
Figure 62. Southeast Asia Human Growth Hormone Drugs Revenue Growth 2020-2025 ($ millions)
Figure 63. India Human Growth Hormone Drugs Revenue Growth 2020-2025 ($ millions)
Figure 64. Australia Human Growth Hormone Drugs Revenue Growth 2020-2025 ($ millions)
Figure 65. China Taiwan Human Growth Hormone Drugs Revenue Growth 2020-2025 ($ millions)
Figure 66. Europe Human Growth Hormone Drugs Sales Market Share by Country in 2025
Figure 67. Europe Human Growth Hormone Drugs Revenue Market Share by Country (2020-2025)
Figure 68. Europe Human Growth Hormone Drugs Sales Market Share by Type (2020-2025)
Figure 69. Europe Human Growth Hormone Drugs Sales Market Share by Application (2020-2025)
Figure 70. Germany Human Growth Hormone Drugs Revenue Growth 2020-2025 ($ millions)
Figure 71. France Human Growth Hormone Drugs Revenue Growth 2020-2025 ($ millions)
Figure 72. UK Human Growth Hormone Drugs Revenue Growth 2020-2025 ($ millions)
Figure 73. Italy Human Growth Hormone Drugs Revenue Growth 2020-2025 ($ millions)
Figure 74. Russia Human Growth Hormone Drugs Revenue Growth 2020-2025 ($ millions)
Figure 75. Middle East & Africa Human Growth Hormone Drugs Sales Market Share by Country (2020-2025)
Figure 76. Middle East & Africa Human Growth Hormone Drugs Sales Market Share by Type (2020-2025)
Figure 77. Middle East & Africa Human Growth Hormone Drugs Sales Market Share by Application (2020-2025)
Figure 78. Egypt Human Growth Hormone Drugs Revenue Growth 2020-2025 ($ millions)
Figure 79. South Africa Human Growth Hormone Drugs Revenue Growth 2020-2025 ($ millions)
Figure 80. Israel Human Growth Hormone Drugs Revenue Growth 2020-2025 ($ millions)
Figure 81. Turkey Human Growth Hormone Drugs Revenue Growth 2020-2025 ($ millions)
Figure 82. GCC Countries Human Growth Hormone Drugs Revenue Growth 2020-2025 ($ millions)
Figure 83. Manufacturing Cost Structure Analysis of Human Growth Hormone Drugs in 2025
Figure 84. Manufacturing Process Analysis of Human Growth Hormone Drugs
Figure 85. Industry Chain Structure of Human Growth Hormone Drugs
Figure 86. Channels of Distribution
Figure 87. Global Human Growth Hormone Drugs Sales Market Forecast by Region (2026-2031)
Figure 88. Global Human Growth Hormone Drugs Revenue Market Share Forecast by Region (2026-2031)
Figure 89. Global Human Growth Hormone Drugs Sales Market Share Forecast by Type (2026-2031)
Figure 90. Global Human Growth Hormone Drugs Revenue Market Share Forecast by Type (2026-2031)
Figure 91. Global Human Growth Hormone Drugs Sales Market Share Forecast by Application (2026-2031)
Figure 92. Global Human Growth Hormone Drugs Revenue Market Share Forecast by Application (2026-2031)
Figure 1. Picture of Human Growth Hormone Drugs
Figure 2. Human Growth Hormone Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Human Growth Hormone Drugs Sales Growth Rate 2020-2031 (K Pcs)
Figure 7. Global Human Growth Hormone Drugs Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Human Growth Hormone Drugs Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Human Growth Hormone Drugs Sales Market Share by Country/Region (2024)
Figure 10. Human Growth Hormone Drugs Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Norditropin
Figure 12. Product Picture of Genotropin
Figure 13. Product Picture of Humatrope
Figure 14. Product Picture of Saizen
Figure 15. Product Picture of Omnitrope - the Somatropin Biosimilar
Figure 16. Product Picture of Somatropin Biopartners
Figure 17. Global Human Growth Hormone Drugs Sales Market Share by Type in 2025
Figure 18. Global Human Growth Hormone Drugs Revenue Market Share by Type (2020-2025)
Figure 19. Human Growth Hormone Drugs Consumed in Prader-Willi Syndrome
Figure 20. Global Human Growth Hormone Drugs Market: Prader-Willi Syndrome (2020-2025) & (K Pcs)
Figure 21. Human Growth Hormone Drugs Consumed in Turner Syndrome
Figure 22. Global Human Growth Hormone Drugs Market: Turner Syndrome (2020-2025) & (K Pcs)
Figure 23. Human Growth Hormone Drugs Consumed in Short Stature Homeobox Gene
Figure 24. Global Human Growth Hormone Drugs Market: Short Stature Homeobox Gene (2020-2025) & (K Pcs)
Figure 25. Human Growth Hormone Drugs Consumed in Small for Gestational Age
Figure 26. Global Human Growth Hormone Drugs Market: Small for Gestational Age (2020-2025) & (K Pcs)
Figure 27. Human Growth Hormone Drugs Consumed in Chronic Renal Insufficiency
Figure 28. Global Human Growth Hormone Drugs Market: Chronic Renal Insufficiency (2020-2025) & (K Pcs)
Figure 29. Human Growth Hormone Drugs Consumed in Short Bowel Syndrome
Figure 30. Global Human Growth Hormone Drugs Market: Short Bowel Syndrome (2020-2025) & (K Pcs)
Figure 31. Global Human Growth Hormone Drugs Sale Market Share by Application (2024)
Figure 32. Global Human Growth Hormone Drugs Revenue Market Share by Application in 2025
Figure 33. Human Growth Hormone Drugs Sales by Company in 2025 (K Pcs)
Figure 34. Global Human Growth Hormone Drugs Sales Market Share by Company in 2025
Figure 35. Human Growth Hormone Drugs Revenue by Company in 2025 ($ millions)
Figure 36. Global Human Growth Hormone Drugs Revenue Market Share by Company in 2025
Figure 37. Global Human Growth Hormone Drugs Sales Market Share by Geographic Region (2020-2025)
Figure 38. Global Human Growth Hormone Drugs Revenue Market Share by Geographic Region in 2025
Figure 39. Americas Human Growth Hormone Drugs Sales 2020-2025 (K Pcs)
Figure 40. Americas Human Growth Hormone Drugs Revenue 2020-2025 ($ millions)
Figure 41. APAC Human Growth Hormone Drugs Sales 2020-2025 (K Pcs)
Figure 42. APAC Human Growth Hormone Drugs Revenue 2020-2025 ($ millions)
Figure 43. Europe Human Growth Hormone Drugs Sales 2020-2025 (K Pcs)
Figure 44. Europe Human Growth Hormone Drugs Revenue 2020-2025 ($ millions)
Figure 45. Middle East & Africa Human Growth Hormone Drugs Sales 2020-2025 (K Pcs)
Figure 46. Middle East & Africa Human Growth Hormone Drugs Revenue 2020-2025 ($ millions)
Figure 47. Americas Human Growth Hormone Drugs Sales Market Share by Country in 2025
Figure 48. Americas Human Growth Hormone Drugs Revenue Market Share by Country (2020-2025)
Figure 49. Americas Human Growth Hormone Drugs Sales Market Share by Type (2020-2025)
Figure 50. Americas Human Growth Hormone Drugs Sales Market Share by Application (2020-2025)
Figure 51. United States Human Growth Hormone Drugs Revenue Growth 2020-2025 ($ millions)
Figure 52. Canada Human Growth Hormone Drugs Revenue Growth 2020-2025 ($ millions)
Figure 53. Mexico Human Growth Hormone Drugs Revenue Growth 2020-2025 ($ millions)
Figure 54. Brazil Human Growth Hormone Drugs Revenue Growth 2020-2025 ($ millions)
Figure 55. APAC Human Growth Hormone Drugs Sales Market Share by Region in 2025
Figure 56. APAC Human Growth Hormone Drugs Revenue Market Share by Region (2020-2025)
Figure 57. APAC Human Growth Hormone Drugs Sales Market Share by Type (2020-2025)
Figure 58. APAC Human Growth Hormone Drugs Sales Market Share by Application (2020-2025)
Figure 59. China Human Growth Hormone Drugs Revenue Growth 2020-2025 ($ millions)
Figure 60. Japan Human Growth Hormone Drugs Revenue Growth 2020-2025 ($ millions)
Figure 61. South Korea Human Growth Hormone Drugs Revenue Growth 2020-2025 ($ millions)
Figure 62. Southeast Asia Human Growth Hormone Drugs Revenue Growth 2020-2025 ($ millions)
Figure 63. India Human Growth Hormone Drugs Revenue Growth 2020-2025 ($ millions)
Figure 64. Australia Human Growth Hormone Drugs Revenue Growth 2020-2025 ($ millions)
Figure 65. China Taiwan Human Growth Hormone Drugs Revenue Growth 2020-2025 ($ millions)
Figure 66. Europe Human Growth Hormone Drugs Sales Market Share by Country in 2025
Figure 67. Europe Human Growth Hormone Drugs Revenue Market Share by Country (2020-2025)
Figure 68. Europe Human Growth Hormone Drugs Sales Market Share by Type (2020-2025)
Figure 69. Europe Human Growth Hormone Drugs Sales Market Share by Application (2020-2025)
Figure 70. Germany Human Growth Hormone Drugs Revenue Growth 2020-2025 ($ millions)
Figure 71. France Human Growth Hormone Drugs Revenue Growth 2020-2025 ($ millions)
Figure 72. UK Human Growth Hormone Drugs Revenue Growth 2020-2025 ($ millions)
Figure 73. Italy Human Growth Hormone Drugs Revenue Growth 2020-2025 ($ millions)
Figure 74. Russia Human Growth Hormone Drugs Revenue Growth 2020-2025 ($ millions)
Figure 75. Middle East & Africa Human Growth Hormone Drugs Sales Market Share by Country (2020-2025)
Figure 76. Middle East & Africa Human Growth Hormone Drugs Sales Market Share by Type (2020-2025)
Figure 77. Middle East & Africa Human Growth Hormone Drugs Sales Market Share by Application (2020-2025)
Figure 78. Egypt Human Growth Hormone Drugs Revenue Growth 2020-2025 ($ millions)
Figure 79. South Africa Human Growth Hormone Drugs Revenue Growth 2020-2025 ($ millions)
Figure 80. Israel Human Growth Hormone Drugs Revenue Growth 2020-2025 ($ millions)
Figure 81. Turkey Human Growth Hormone Drugs Revenue Growth 2020-2025 ($ millions)
Figure 82. GCC Countries Human Growth Hormone Drugs Revenue Growth 2020-2025 ($ millions)
Figure 83. Manufacturing Cost Structure Analysis of Human Growth Hormone Drugs in 2025
Figure 84. Manufacturing Process Analysis of Human Growth Hormone Drugs
Figure 85. Industry Chain Structure of Human Growth Hormone Drugs
Figure 86. Channels of Distribution
Figure 87. Global Human Growth Hormone Drugs Sales Market Forecast by Region (2026-2031)
Figure 88. Global Human Growth Hormone Drugs Revenue Market Share Forecast by Region (2026-2031)
Figure 89. Global Human Growth Hormone Drugs Sales Market Share Forecast by Type (2026-2031)
Figure 90. Global Human Growth Hormone Drugs Revenue Market Share Forecast by Type (2026-2031)
Figure 91. Global Human Growth Hormone Drugs Sales Market Share Forecast by Application (2026-2031)
Figure 92. Global Human Growth Hormone Drugs Revenue Market Share Forecast by Application (2026-2031)
More Publications
Global Pediatric Implantable Port Market Growth 2026-2032
US$ 3,660.00
May 2026
112 pages
Global Whole Slide Imaging Systems Market Growth (Status and Outlook) 2023-2029
US$ 3,660.00
March 2023
101 pages
Global Memory Enhancing Drug Market Growth (Status and Outlook) 2025-2031
US$ 3,660.00
September 2025
104 pages
Global Gel Imaging Documentation Market Growth 2024-2030
US$ 3,660.00
March 2024
133 pages
